Coping strategies for pertussis resurgence

X Nian, H Liu, M Cai, K Duan, X Yang - Vaccines, 2023 - mdpi.com
Pertussis (whooping cough) is a respiratory disease caused primarily by Bordetella
pertussis, a Gram-negative bacteria. Pertussis is a relatively contagious infectious disease in …

The neonatal immune system and respiratory pathogens

CJ Sedney, ET Harvill - Microorganisms, 2023 - mdpi.com
Neonates are more susceptible to some pathogens, particularly those that cause infection in
the respiratory tract. This is often attributed to an incompletely developed immune system …

Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice

J Holubová, O Staněk, L Brázdilová, J Mašín, L Bumba… - Vaccines, 2020 - mdpi.com
Bordetella pertussis whole-cell vaccines (wP) caused a spectacular drop of global pertussis
incidence, but since the replacement of wP with acellular pertussis vaccines (aP), pertussis …

Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis

DT Boehm, MA Wolf, JM Hall, TY Wong, E Sen-Kilic… - npj Vaccines, 2019 - nature.com
Current acellular pertussis vaccines fall short of optimal protection against the human
respiratory pathogen Bordetella pertussis resulting in increased incidence of a previously …

Intranasal immunization with acellular pertussis vaccines results in long-term immunity to Bordetella pertussis in mice

MA Wolf, DT Boehm, MA DeJong, TY Wong… - Infection and …, 2021 - Am Soc Microbiol
Bordetella pertussis colonizes the respiratory mucosa of humans, inducing an immune
response seeded in the respiratory tract. An individual, once convalescent, exhibits long …

Intranasal challenge with B. pertussis leads to more severe disease manifestations in mice than aerosol challenge

KL Weaver, GJ Bitzer, MA Wolf, GM Pyles, MA DeJong… - Plos one, 2023 - journals.plos.org
The murine Bordetella pertussis challenge model has been utilized in preclinical research
for decades. Currently, inconsistent methodologies are employed by researchers across the …

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B …

KS Yount, JM Hall, K Caution, MM Shamseldin… - Frontiers in …, 2023 - frontiersin.org
Introduction Resurgence of pertussis, caused by Bordetella pertussis, necessitates novel
vaccines and vaccination strategies to combat this disease. Alum-adjuvanted acellular …

A Review on T Cell Epitopes Identified Using Prediction and Cell-Mediated Immune Models for Mycobacterium tuberculosis and Bordetella pertussis

Y Tian, R da Silva Antunes, J Sidney… - Frontiers in …, 2018 - frontiersin.org
In the present review, we summarize work from our as well as other groups related to the
characterization of bacterial T cell epitopes, with a specific focus on two important …

Next-generation pertussis vaccines based on the induction of protective T cells in the respiratory tract

CN Chasaide, KHG Mills - Vaccines, 2020 - mdpi.com
Immunization with current acellular pertussis (aP) vaccines protects against severe
pertussis, but immunity wanes rapidly after vaccination and these vaccines do not prevent …

Multivalent mRNA-DTP vaccines are immunogenic and provide protection from Bordetella pertussis challenge in mice

MA Wolf, JM O'Hara, GJ Bitzer, E Narayanan… - npj Vaccines, 2024 - nature.com
Acellular multivalent vaccines for pertussis (DTaP and Tdap) prevent symptomatic disease
and infant mortality, but immunity to Bordetella pertussis infection wanes significantly over …